Jelena Drulovic1, Vanja Basic-Kes2, Sanja Grgic3, Slobodan Vojinovic3, Evica Dincic4, Gordana Toncev5, Mira Gavric Kezic6, Darija Kisic-Tepavcevic7, Irena Dujmovic1, Sarlota Mesaros1, Svetlana Miletic-Drakulic6, Tatjana Pekmezovic8. 1. Clinic of Neurology, Clinical Center of Serbia, Belgrade, Serbia. 2. University Department of Neurology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia. 3. Clinic of Neurology, Clinical Center Banja Luka, Banja Luka, Republic of Srpska-Bosnia and, Herzegovina. 4. Clinic of Neurology, Clinical Center Nis, Nis, Serbia. 5. Clinic of Neurology, Military Medical Academy, Belgrade, Serbia. 6. Clinic of Neurology, Clinical Center Kragujevac, Kragujevac, Serbia. 7. Department of Neurology, General hospital-Uzice. 8. Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Abstract
OBJECTIVE: Examination of prevalence, intensity and associations of pain in persons with multiple sclerosis (MS). DESIGN: Multicenter, international cross-sectional survey. SETTING: Patients were recruited from seven MS centers: in Serbia (Clinic of Neurology, Clinical Center of Serbia, Belgrade; Clinic of Neurology, Military Medical Academy, Belgrade; Clinic of Neurology, Clinical Center Kragujevac; Clinic of Neurology, Clinical Center Nis; Department of Neurology, General Hospital-Uzice), in Republic of Srpska-Bosnia and Herzegovina (Clinic of Neurology, Clinical Center Banja Luka) and in Croatia (University Department of Neurology, Sestre Milosrdnice University Hospital Center, Zagreb). SUBJECTS: Six hundred and fifty consecutive MS patients diagnosed according to the Revised McDonald criteria (2005), from the aforementioned centers, over the period of 6 months. METHODS: A semistructured questionnaire was administered during a face-to-face interview with neurologists who also performed Expanded Disability Status Scale (EDSS), the Hamilton Rating Scale for Depression (HDRS) and Hamilton Rating Scale for Anxiety (HARS). To recognize predictive factors for the presence of pain, the linear regression analysis was used. RESULTS: Lifetime prevalence of pain was 66.5% (point prevalence = 44.3%). The prevalence of the comorbidity of pain and depression was 29.1%. Older age (P < 0.001), primary-progressive MS (P = 0.034), higher EDSS score (P = 0.008), higher scores of HDRS (P < 0.001), and HARS (P < 0.001) were significantly associated with pain. Finally, in our multivariate linear regression analysis, anxiety (P < 0.001) was the independent predictor of pain. CONCLUSIONS: We confirmed high prevalence of pain, affecting approximately more than half of patients during the course of MS. Pain in MS is associated with disability, depression and, especially with anxiety, which has significant implications for treatment. Wiley Periodicals, Inc.
OBJECTIVE: Examination of prevalence, intensity and associations of pain in persons with multiple sclerosis (MS). DESIGN: Multicenter, international cross-sectional survey. SETTING:Patients were recruited from seven MS centers: in Serbia (Clinic of Neurology, Clinical Center of Serbia, Belgrade; Clinic of Neurology, Military Medical Academy, Belgrade; Clinic of Neurology, Clinical Center Kragujevac; Clinic of Neurology, Clinical Center Nis; Department of Neurology, General Hospital-Uzice), in Republic of Srpska-Bosnia and Herzegovina (Clinic of Neurology, Clinical Center Banja Luka) and in Croatia (University Department of Neurology, Sestre Milosrdnice University Hospital Center, Zagreb). SUBJECTS: Six hundred and fifty consecutive MS patients diagnosed according to the Revised McDonald criteria (2005), from the aforementioned centers, over the period of 6 months. METHODS: A semistructured questionnaire was administered during a face-to-face interview with neurologists who also performed Expanded Disability Status Scale (EDSS), the Hamilton Rating Scale for Depression (HDRS) and Hamilton Rating Scale for Anxiety (HARS). To recognize predictive factors for the presence of pain, the linear regression analysis was used. RESULTS: Lifetime prevalence of pain was 66.5% (point prevalence = 44.3%). The prevalence of the comorbidity of pain and depression was 29.1%. Older age (P < 0.001), primary-progressive MS (P = 0.034), higher EDSS score (P = 0.008), higher scores of HDRS (P < 0.001), and HARS (P < 0.001) were significantly associated with pain. Finally, in our multivariate linear regression analysis, anxiety (P < 0.001) was the independent predictor of pain. CONCLUSIONS: We confirmed high prevalence of pain, affecting approximately more than half of patients during the course of MS. Pain in MS is associated with disability, depression and, especially with anxiety, which has significant implications for treatment. Wiley Periodicals, Inc.
Authors: Samuel S Duffy; Brooke A Keating; Chamini J Perera; Justin G Lees; Ryan S Tonkin; Preet G S Makker; Pascal Carrive; Oleg Butovsky; Gila Moalem-Taylor Journal: J Neurosci Date: 2019-01-16 Impact factor: 6.167
Authors: Suzanne Doolen; Tommaso Iannitti; Renee R Donahue; Benjamin C Shaw; Carolyn M Grachen; Bradley K Taylor Journal: Pain Date: 2018-02 Impact factor: 7.926
Authors: Samuel S Duffy; Chamini J Perera; Preet G S Makker; Justin G Lees; Pascal Carrive; Gila Moalem-Taylor Journal: Front Immunol Date: 2016-09-22 Impact factor: 7.561
Authors: Claudia H Marck; Alysha M De Livera; Tracey J Weiland; Pia L Jelinek; Sandra L Neate; Chelsea R Brown; Keryn L Taylor; Fary Khan; George A Jelinek Journal: Front Neurol Date: 2017-09-05 Impact factor: 4.003
Authors: Valentina Pegoretti; Kathryn A Swanson; John R Bethea; Lesley Probert; Ulrich L M Eisel; Roman Fischer Journal: Oxid Med Cell Longev Date: 2020-05-12 Impact factor: 6.543